Cargando…

Clinical Application of Pharmacogenetic Markers in the Treatment of Dermatologic Pathologies

Dermatologic pathologies are the fourth most common cause of non-fatal disease worldwide; however, they produce a psychosocial, economic, and occupational impact equal to or greater than other chronic conditions. The most prevalent are actinic keratosis, followed by basal-cell carcinoma, in a lesser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Membrive Jiménez, Cristina, Pérez Ramírez, Cristina, Sánchez Martín, Almudena, Vieira Maroun, Sayleth, Arias Santiago, Salvador, Ramírez Tortosa, María Carmen, Jiménez Morales, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471650/ https://www.ncbi.nlm.nih.gov/pubmed/34577605 http://dx.doi.org/10.3390/ph14090905

Ejemplares similares

Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis
por: Membrive Jiménez, Cristina, et al.
Publicado: (2021)

ABCC1, ABCG2 and FOXP3: Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis
por: Membrive-Jiménez, Cristina, et al.
Publicado: (2023)

Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis
por: Membrive-Jiménez, Cristina, et al.
Publicado: (2023)

Influence of Single-Nucleotide Polymorphisms on Clinical Outcomes of Capecitabine-Based Chemotherapy in Colorectal Cancer Patients: A Systematic Review
por: Cura, Yasmin, et al.
Publicado: (2023)

Polymorphisms in VDR, CYP27B1, CYP2R1, GC and CYP24A1 Genes as Biomarkers of Survival in Non-Small Cell Lung Cancer: A Systematic Review
por: Pineda-Lancheros, Laura Elena, et al.
Publicado: (2023)

Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway and Their Relationship with High Blood Pressure Risk
por: Rojo-Tolosa, Susana, et al.
Publicado: (2023)

Hypoxia-Inducible Factor-1 Alpha Expression Is Predictive of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Ramírez-Tortosa, César L., et al.
Publicado: (2022)

Impact of Genetic Polymorphisms on the Metabolic Pathway of Vitamin D and Survival in Non-Small Cell Lung Cancer
por: Pineda Lancheros, Laura Elena, et al.
Publicado: (2021)

Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis
por: Zarzuelo Romero, María José, et al.
Publicado: (2021)

Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients
por: Zarzuelo-Romero, María José, et al.
Publicado: (2021)

Impact of Single-Nucleotide Polymorphisms of CTLA-4, CD80 and CD86 on the Effectiveness of Abatacept in Patients with Rheumatoid Arthritis
por: Marquez Pete, Noelia, et al.
Publicado: (2020)

Vitamin D-Related Single Nucleotide Polymorphisms as Risk Biomarker of Cardiovascular Disease
por: González Rojo, Paula, et al.
Publicado: (2022)

Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients
por: Cura, Yasmin, et al.
Publicado: (2023)

Pharmacogenetics of response to neoadjuvant paclitaxel treatment for locally advanced breast cancer
por: Perez-Ortiz, Andric C., et al.
Publicado: (2017)

Effect of Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway on Susceptibility to Non-Small-Cell Lung Cancer
por: Pineda Lancheros, Laura Elena, et al.
Publicado: (2022)

Comparative Analysis of Quality of Life of Patients with Dermatological Problems: Teledermatology Versus Face-to-Face Dermatology
por: Lopez-Liria, Remedios, et al.
Publicado: (2022)

Hydroxytyrosol Supplementation Modifies Plasma Levels of Tissue Inhibitor of Metallopeptidase 1 in Women with Breast Cancer
por: Ramirez-Tortosa, Cesar, et al.
Publicado: (2019)

The Role of Exosomes Derived From Mesenchymal Stromal Cells in Dermatology
por: Quiñones-Vico, María I., et al.
Publicado: (2021)

Burnout in Palliative Care Nurses, Prevalence and Risk Factors: A Systematic Review with Meta-Analysis
por: Gómez-Urquiza, Jose Luis, et al.
Publicado: (2020)

Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico
por: Gonzalez-Covarrubias, Vanessa, et al.
Publicado: (2019)

Single Nucleotide Polymorphisms in the Vitamin D Metabolic Pathway as Survival Biomarkers in Colorectal Cancer
por: Pérez-Durán, Carmen, et al.
Publicado: (2023)

An Acenocoumarol Dosing Algorithm Using Clinical and Pharmacogenetic Data in Spanish Patients with Thromboembolic Disease
por: Borobia, Alberto M., et al.
Publicado: (2012)

Actionable pharmacogenetic markers for prediction and prognosis in breast cancer
por: Sacco, Keith, et al.
Publicado: (2015)

Factors related to the appearance and development of burnout in nursing students: a systematic review and meta-analysis
por: Velando-Soriano, Almudena, et al.
Publicado: (2023)

Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy
por: Peña-Martín, María Celsa, et al.
Publicado: (2022)

Exploring Patients’ Insight, Concerns, and Expectations at Dermatology Clinic: An Observational Study in 2 Centers in Scotland and Spain
por: Martínez-García, Eliseo, et al.
Publicado: (2020)

KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment
por: Ruiz-Iruela, Cristina, et al.
Publicado: (2018)

Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina
por: Ašić, Adna, et al.
Publicado: (2019)

HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population
por: Nakkam, Nontaya, et al.
Publicado: (2018)

Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype
por: Marcos-Vadillo, Elena, et al.
Publicado: (2022)

Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma
por: Alonso-Peña, Marta, et al.
Publicado: (2019)

Pharmacogenetics of FSH Action in the Male
por: Schubert, Maria, et al.
Publicado: (2019)

Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study
por: Rojo-Tolosa, Susana, et al.
Publicado: (2023)

Impact of Anti-IL5 Therapies on Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study
por: Rojo-Tolosa, Susana, et al.
Publicado: (2023)

Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype
por: Rojo-Tolosa, Susana, et al.
Publicado: (2023)

Nation-Wide Survey Assessing the Knowledge and Attitudes of Romanian Pharmacists Concerning Pharmacogenetics
por: Pop, Cristina, et al.
Publicado: (2022)

Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years
por: Borobia, Alberto M., et al.
Publicado: (2017)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

Ischemia-Modified Albumin—A Potential New Marker of Oxidative Stress in Dermatological Diseases
por: Tampa, Mircea, et al.
Publicado: (2022)

Cancer pharmacogenetics
por: Marsh, S, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_bieck1qmqe7kejsn3ibbmhn3hn